BIOMAT Database Logo BIOMAT Database Logo

[Tobramycin concentrations in cerebrospinal fluid]. 1974

P Veyssier, and C Carbon, and Y Boussougant, and C Mariel, and S Lamotte-Barillon, and A Domart

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007278 Injections, Spinal Introduction of therapeutic agents into the spinal region using a needle and syringe. Injections, Intraspinal,Injections, Intrathecal,Intraspinal Injections,Intrathecal Injections,Spinal Injections,Injection, Intraspinal,Injection, Intrathecal,Injection, Spinal,Intraspinal Injection,Intrathecal Injection,Spinal Injection
D008581 Meningitis Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6) Pachymeningitis,Meningitides,Pachymeningitides
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004058 Diffusion The tendency of a gas or solute to pass from a point of higher pressure or concentration to a point of lower pressure or concentration and to distribute itself throughout the available space. Diffusion, especially FACILITATED DIFFUSION, is a major mechanism of BIOLOGICAL TRANSPORT. Diffusions
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013223 Statistics as Topic Works about the science and art of collecting, summarizing, and analyzing data that are subject to random variation. Area Analysis,Estimation Technics,Estimation Techniques,Indirect Estimation Technics,Indirect Estimation Techniques,Multiple Classification Analysis,Service Statistics,Statistical Study,Statistics, Service,Tables and Charts as Topic,Analyses, Area,Analyses, Multiple Classification,Area Analyses,Classification Analyses, Multiple,Classification Analysis, Multiple,Estimation Technic, Indirect,Estimation Technics, Indirect,Estimation Technique,Estimation Technique, Indirect,Estimation Techniques, Indirect,Indirect Estimation Technic,Indirect Estimation Technique,Multiple Classification Analyses,Statistical Studies,Studies, Statistical,Study, Statistical,Technic, Indirect Estimation,Technics, Estimation,Technics, Indirect Estimation,Technique, Estimation,Technique, Indirect Estimation,Techniques, Estimation,Techniques, Indirect Estimation

Related Publications

P Veyssier, and C Carbon, and Y Boussougant, and C Mariel, and S Lamotte-Barillon, and A Domart
Concentrations of ceftazidime, tobramycin and ampicillin in the cerebrospinal fluid of newborn infants.
June 1989, European journal of pediatrics,
P Veyssier, and C Carbon, and Y Boussougant, and C Mariel, and S Lamotte-Barillon, and A Domart
Lactate concentrations in cerebrospinal fluid.
August 1980, The Journal of infectious diseases,
P Veyssier, and C Carbon, and Y Boussougant, and C Mariel, and S Lamotte-Barillon, and A Domart
Cerebrospinal fluid digoxin concentrations in humans.
January 1978, Journal of clinical pharmacology,
P Veyssier, and C Carbon, and Y Boussougant, and C Mariel, and S Lamotte-Barillon, and A Domart
Low atazanavir concentrations in cerebrospinal fluid.
January 2009, AIDS (London, England),
P Veyssier, and C Carbon, and Y Boussougant, and C Mariel, and S Lamotte-Barillon, and A Domart
Cerebrospinal Fluid Protein Concentrations in Hydrocephalus.
March 2023, Children (Basel, Switzerland),
P Veyssier, and C Carbon, and Y Boussougant, and C Mariel, and S Lamotte-Barillon, and A Domart
Therapeutic amprenavir concentrations in cerebrospinal fluid.
April 2012, Antimicrobial agents and chemotherapy,
P Veyssier, and C Carbon, and Y Boussougant, and C Mariel, and S Lamotte-Barillon, and A Domart
Electrolyte concentrations in sheep cerebrospinal fluid.
May 1977, Research in veterinary science,
P Veyssier, and C Carbon, and Y Boussougant, and C Mariel, and S Lamotte-Barillon, and A Domart
Pentachlorophenol concentrations in human cerebrospinal fluid.
January 1991, Neurotoxicology,
P Veyssier, and C Carbon, and Y Boussougant, and C Mariel, and S Lamotte-Barillon, and A Domart
Tobramycin levels in cerebrospinal fluid of patients with slightly and severely impaired blood-cerebrospinal barrier.
January 1981, Chemotherapy,
P Veyssier, and C Carbon, and Y Boussougant, and C Mariel, and S Lamotte-Barillon, and A Domart
[P-hydroxyphenylacetic acid concentrations in cerebrospinal fluid].
August 1982, No to shinkei = Brain and nerve,
Copied contents to your clipboard!